The arrival of SARS-CoV-2-neutralizing antibodies in a currently available commercial immunoglobulin.
The Journal of allergy and clinical immunology(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
The Journal of allergy and clinical immunology(2022)